These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 10811847)

  • 1. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
    Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
    Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.
    Lu J; McKinsey TA; Nicol RL; Olson EN
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4070-5. PubMed ID: 10737771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.
    Wu H; Naya FJ; McKinsey TA; Mercer B; Shelton JM; Chin ER; Simard AR; Michel RN; Bassel-Duby R; Olson EN; Williams RS
    EMBO J; 2000 May; 19(9):1963-73. PubMed ID: 10790363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.
    Antos CL; McKinsey TA; Frey N; Kutschke W; McAnally J; Shelton JM; Richardson JA; Hill JA; Olson EN
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):907-12. PubMed ID: 11782539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the human atrial myosin light chain 1 promoter by Ca2+-calmodulin-dependent signaling pathways.
    Woischwill C; Karczewski P; Bartsch H; Luther HP; Kott M; Haase H; Morano I
    FASEB J; 2005 Apr; 19(6):503-11. PubMed ID: 15791000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes.
    Nakagawa Y; Kuwahara K; Harada M; Takahashi N; Yasuno S; Adachi Y; Kawakami R; Nakanishi M; Tanimoto K; Usami S; Kinoshita H; Saito Y; Nakao K
    J Mol Cell Cardiol; 2006 Dec; 41(6):1010-22. PubMed ID: 17011572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
    Molkentin JD
    Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
    Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
    J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
    Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
    Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
    Wilkins BJ; Molkentin JD
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium.
    Kolodziejczyk SM; Wang L; Balazsi K; DeRepentigny Y; Kothary R; Megeney LA
    Curr Biol; 1999 Oct; 9(20):1203-6. PubMed ID: 10531040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling.
    Muñoz JP; Collao A; Chiong M; Maldonado C; Adasme T; Carrasco L; Ocaranza P; Bravo R; Gonzalez L; Díaz-Araya G; Hidalgo C; Lavandero S
    Biochem Biophys Res Commun; 2009 Oct; 388(1):155-60. PubMed ID: 19654000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure.
    van Oort RJ; van Rooij E; Bourajjaj M; Schimmel J; Jansen MA; van der Nagel R; Doevendans PA; Schneider MD; van Echteld CJ; De Windt LJ
    Circulation; 2006 Jul; 114(4):298-308. PubMed ID: 16847152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
    Fiedler B; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.
    Condorelli G; Drusco A; Stassi G; Bellacosa A; Roncarati R; Iaccarino G; Russo MA; Gu Y; Dalton N; Chung C; Latronico MV; Napoli C; Sadoshima J; Croce CM; Ross J
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12333-8. PubMed ID: 12237475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.